(119 days)
Not Found
No
The document describes a standard multi-parameter patient monitor with basic alarm functions and data display. There is no mention of AI, ML, or any advanced analytical capabilities that would suggest the use of these technologies. The software modifications are described as "minor" and addressing "customer requested enhancements," which typically do not involve AI/ML integration.
No.
The device is a multi-parameter patient monitor that measures physiological parameters and provides alarms, but it does not actively treat or intervene to alleviate or cure a medical condition.
Yes
Explanation: The device monitors various physiological parameters and produces alarms if they vary beyond preset limits, which aids in assessing and monitoring the patient's condition.
No
The device description explicitly mentions "physical form" and "hardware modifications for the new Draeger look," indicating it includes hardware components beyond just software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is for "multi-parameter patient monitoring." It measures physiological parameters directly from the patient (heart rate, respiration rate, blood pressure, temperature, etc.).
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description: The description focuses on the physical form, software modifications, and alarm indicators, all related to patient monitoring.
- Input: The device takes physiological signals directly from the patient, not samples from the patient.
- Output: The output is real-time physiological data and alarms, not diagnostic results from analyzing a sample.
While the device does have modules that sample breathing gases (SCIO and MultiGas/MultiGas+), this is still a form of monitoring the patient's physiological state (gas exchange during breathing) rather than performing a diagnostic test on a collected sample.
Therefore, the INFINITY Modular Monitors fall under the category of patient monitoring devices, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
The INFINITY Modular monitors are capable of monitoring:
- . Heart rate
- Respiration rate .
- . Invasive pressure
- Non-invasive pressure
- . Arrhythmia
- Temperature
- . Cardiac output
- Arterial oxygen saturation .
- . Pulse rate
- . Apnea
- ST Segment Analysis .
- 12-Lead ST Segment Analysis .
- . tcp02/tcpC02
- EEG signals .
- FiO2 .
The SCIO and MultiGas/MultiGas+ modules sample breathing gases from adults and pediatrics. The gas modules continuously measure the content of CO2, N2O, O2 and one of the anesthetic agents, halothane, isoflurane, Enflurane, Sevoflurane and Desflurane in any mixture and communicates real time and derived gas information to the INFINITY monitors.
With etCO2 the monitors can measure end tidal carbon dioxide, inspired carbon dioxide, and respiration rate in either mainstream or side-stream measurement mode; and with etCO2+Respiratory Mechanics, spirometry and carbon dioxide can be monitored. The monitors can interface with specific third party devices via an MIB protocol converter.
Product codes (comma separated list FDA assigned to the subject device)
MHX
Device Description
The VF4 release of the INFINITY Modular monitors supports the "look and feel" of the Draeger Medical product line, including the Draeger logo, colors, menu structure, and physical form. An alarm indicator has been added to the top center of the device that illuminates in red or vellow for the purpose of displaying both life threatening and serious alarms respectively.
Additional minor software modifications have been implemented that primarily address customer requested enhancements.
Testing in accordance with internal design control procedures has verified that the INFINITY Modular Monitors with VF4 modifications are as safe and effective as the previous released versions of the monitors.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult, Pediatric and Neonatal populations, with the exception of the parameter Cardiac Output, ST Segment Analysis, and arrhythmia which are intended for use in the adult and pediatric populations only; and tcpO2 which is to be used in the neonatal population only when the patient is not under gas anesthesia.
Intended User / Care Setting
The devices are intended to be used in the environment where patient care is provided by Healthcare Professionals, i.e. Physicians, Nurses, and Technicians, who will determine when use of the device is indicated, based upon their professional assessment of the patient's medical condition.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Verification and validation testing of VF4 software, as well as testing applicable to the hardware modifications for the new Draeger look indicate no new issues relative to safety and efficacy.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K983632, K990563, K031340, K003243, K982730, K980882
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.
0
Special 510(k) Notification INFINITY Modular Monitors with VF4 Modifications
510(k) SUMMARY
as required per 807.92(c)
Submitters Name, Address:
Draeger Medical Systems, Inc. 16 Electronics Avenue Danvers, MA 01923 Tel: (978) 907-7500 Fax: (978) 750-6879 Official Correspondent: Connie Hertel, Director Quality Assurance & Regulatory Affairs Contact person for this submission: Penelope H. Greco Date submission was prepared: November 21, 2003
Trade Name, Common Name and Classification Name:
-
A. Trade Name:
INFINITY Modular Monitors (Delta / DeltaXL / Kappa and SC 7000 / SC 9000XL / SC 8000) -
B. Common Name, Classification Name, Class and Regulation Number:
| Common Name | Product Code | Class | Regulation Number |
|---|---|---|---|
| Monitor, Physiological, Patient (with | |||
| arrhythmia detection or alarms) | MHX | II | 21 CFR 870.1025 |
| Arrhythmia detector & Alarm | 74DSI | II | 21 CFR 870.1025 |
Legally Marketed Device Identification:
INFINITY SC 8000 Monitor, K983632 / K990563 INFINITY SC 7000 / SC 9000XL Modular Monitors, K031340, K003243/K982730/ K980882
Description of Modification:
The VF4 release of the INFINITY Modular monitors supports the "look and feel" of the Draeger Medical product line, including the Draeger logo, colors, menu structure, and physical form. An alarm indicator has been added to the top center of the device that illuminates in red or vellow for the purpose of displaying both life threatening and serious alarms respectively.
Additional minor software modifications have been implemented that primarily address customer requested enhancements.
Testing in accordance with internal design control procedures has verified that the INFINITY Modular Monitors with VF4 modifications are as safe and effective as the previous released versions of the monitors.
1 of 2
Draeger Medical Systems, Inc.
16 Electronics Avenue Danvers, MA 01923
Tel: (978) 907-7500 Fax: (978) 750-6879
1
Intended Use:
The INFINITY Modular Monitors are intended for multi-parameter patient monitoring. The devices will produce visual and audible alarms if any of the physiological parameters monitored vary beyond preset limits and timed or alarm recordings will be produced. These devices will connect to an R50 Bedside recorder, either directly or via the INFINITY Network.
Assessment of non-clinical performance data for equivalence:
Verification and validation testing of VF4 software, as well as testing applicable to the hardware modifications for the new Draeger look indicate no new issues relative to safety and efficacy.
Assessment of clinical performance data for equivalence: Not applicable
Biocompatability: Not applicable
Sterilization: Not applicable
Standards and Guidances:
IEEE 802.11 Reviewer Guidance for Premarket Notification 510(k) Submissions, November 1993
2 of 2
Draeger Medical Systems, Inc.
16 Electronics Avenue Danvers, MA 01923
Tel: (978) 907-7500 Fax: (978) 750-6879
2
Image /page/2/Picture/11 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of an eagle or bird in flight, composed of three curved lines. The bird is positioned to the right of a circular arrangement of text. The text reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA".
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 2 2 2004
Draeger Medical Systems, Inc. c/o Ms. Penelope H. Greco Regulatory Submission Manager 16 Electronics Avenue Danvers, MA 01923
Re: K033694
Trade Name: INFINITY Modular Monitors (Delta / DeltaXL / Kappa and SC 7000 / SC 9000XL / SC 8000) Regulation Number: 21 CFR 870.1025 Regulation Name: Arrythmia Detector and Alarm Regulatory Class: II (two) Product Code: MHX Dated: November 21, 2003 Received: November 24, 2003
Dear Ms. Greco:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 -- Ms. Penelope H. Greco
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4648. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Dma R. Vochner
Image /page/3/Picture/5 description: The image shows a signature on the left and the letters 'E' and 'D' on the right. The signature is illegible, but it appears to be written in cursive. The letters 'E' and 'D' are in uppercase and are next to each other. The image is simple and contains only these elements.
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known):_ Ko33694
Device Name:___INFINITY Modular Monitors
Indications for Use:
The INFINITY Modular monitors are capable of monitoring:
- . Heart rate
- Respiration rate .
- . Invasive pressure
- Non-invasive pressure
- . Arrhythmia
- Temperature
- . Cardiac output
- Arterial oxygen saturation .
- . Pulse rate
- . Apnea
- ST Segment Analysis .
- 12-Lead ST Segment Analysis .
- . tcp02/tcpC02
- EEG signals .
- FiO2 .
Prescription Use ← (Per 21 CFR 801.109)
OR
Over-The-Counter Use_
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Duna R. Vachner
Division Sign-Only
510(k) Number K033694
Page 1 of 2
5
Indications for Use
The SCIO and MultiGas/MultiGas+ modules sample breathing gases from adults and pediatrics. The gas modules continuously measure the content of CO2, N2O, O2 and one of the anesthetic agents, halothane, isoflurane, Enflurane, Sevoflurane and Desflurane in any mixture and communicates real time and derived gas information to the INFINITY monitors.
With etCO2 the monitors can measure end tidal carbon dioxide, inspired carbon dioxide, and respiration rate in either mainstream or side-stream measurement mode; and with etCO2+Respiratory Mechanics, spirometry and carbon dioxide can be monitored. The monitors can interface with specific third party devices via an MIB protocol converter.
The devices are intended to be used in the environment where patient care is provided by Healthcare Professionals, i.e. Physicians, Nurses, and Technicians, who will determine when use of the device is indicated, based upon their professional assessment of the patient's medical condition.
The devices are intended to be used on Adult, Pediatric and Neonatal populations, with the exception of the parameter Cardiac Output, ST Segment Analysis, and arrhythmia which are intended for use in the adult and pediatric populations only; and tcpO2 which is to be used in the neonatal population only when the patient is not under gas anesthesia.
MRI Compatibility Statement:
The INFINITY Modular Monitors are not compatible for use in a MRI magnetic field.
P. Vachner
(Division of Cardiovascular Devices
510(k) Number K033694
Page 2 of 2